Evaluation of 4CMB in the subcutaneous implant test.
D000818:Animals; D001564:Benzo(a)pyrene; D001580:Benzopyrenes; D001713:Biphenyl Compounds / Q000008:administration & dosage*; D002273:Carcinogens / Q000008:administration & dosage; D002471:Cell Transformation, Neoplastic; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004343:Drug Implants; D005260:Female; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000139:chemically induced; D012878:Skin Neoplasms / Q000139:chemically induced
D001580:Benzopyrenes; D001713:Biphenyl Compounds; D002273:Carcinogens; D004343:Drug Implants; D001564:Benzo(a)pyrene; C033487:4-chloromethylbiphenyl